Advancements in vision restoration: CRISPR gives hope to patients
In a revolutionary development, CRISPR gene editing emerged as a beacon of hope for people suffering from genetic blindness. The results of a Phase 1/2 clinical trial revealed promising results, sparking confidence in the medical world and providing a ray of hope to people suffering from vision Read More...
CRISPR gene-editing restores vision in patients with rare eye disease
Researchers from the Casey Eye Institute at the Oregon Health & Science University are reporting the successful use of CRISPR gene-editing to restore vision for patients with a rare eye disease. Leber congenital amaurosis, or LCA, is an uncommon genetic form of vision impairment, but seven Read More...